1-3 of 3
Nils Heyne
Close
Sort by
Journal Articles

Two-Year Efficacy and Safety of Ravulizumab in Adults and Children with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of Two Phase 3 Studies

Bradley P. Dixon, Alvaro Domingo Madris-Aris, Brigitte Adams, David Kavanagh, Hee Gyung Kang, Jimmy Wang, Katherine Garlo, Kazuki Tanaka, Laurence Greenbaum, Masayo Ogawa, Nils Heyne, Seong Heon Kim, Spero Cataland, Sung-Soo Yoon, Yoshitaka Miyakawa, Yosu Luque, Melissa Muff-Luett
Journal: Blood
Blood (2021) 138 (Supplement 1): 769.
https://doi.org/10.1182/blood-2021-145040
Published: 2021
Journal Articles

The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia

Clinical Trials & Observations
Günalp Uzun, Karina Althaus, Anurag Singh, Peter Möller, Ulf Ziemann, Annerose Mengel, Peter Rosenberger, Martina Guthoff, Gabor C. Petzold, Jens Müller, Martin Büchsel, Katharina Feil, Hans Henkes, Nils Heyne, Matthias Maschke, Caroline Limpach, Simon Nagel, Ulrich J. Sachs, Falko Fend, Tamam Bakchoul
Journal: Blood
Blood (2021) 138 (11): 992–996.
https://doi.org/10.1182/blood.2021012479
Published: 2021
Includes: Supplemental data
Journal Articles

High-Cut Off Dialysis In Multiple Myeloma Patients With Dialysis Dependent Acute Renal Failure Shows Durable Renal Recovery: A Long-Term Follow Up Analysis

Britta Besemer, M.D., Martina Guthoff, Lothar Kanz, MD, Nils Heyne, Katja Weisel, MD
Journal: Blood
Blood (2013) 122 (21): 3199.
https://doi.org/10.1182/blood.V122.21.3199.3199
Published: 2013